CRISPR deletion of MIEN1 in breast cancer cells

Timothy Van Treuren, Jamboor K. Vishwanatha

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-Target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.

Original languageEnglish
Article numbere0204976
JournalPLoS ONE
Volume13
Issue number10
DOIs
StatePublished - 1 Oct 2018

Fingerprint

Clustered Regularly Interspaced Short Palindromic Repeats
breast neoplasms
Genes
Cells
Breast Neoplasms
Tumors
Guide RNA
Neoplasms
neoplasms
gene deletion
oncogenes
gene targeting
Oncogenes
disease course
Gene expression
metastasis
Cell Movement
actin
Disease Progression
Actins

Cite this

Van Treuren, Timothy ; Vishwanatha, Jamboor K. / CRISPR deletion of MIEN1 in breast cancer cells. In: PLoS ONE. 2018 ; Vol. 13, No. 10.
@article{6a87397b9b5748a4b5720c704fa5776f,
title = "CRISPR deletion of MIEN1 in breast cancer cells",
abstract = "Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-Target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.",
author = "{Van Treuren}, Timothy and Vishwanatha, {Jamboor K.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1371/journal.pone.0204976",
language = "English",
volume = "13",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

CRISPR deletion of MIEN1 in breast cancer cells. / Van Treuren, Timothy; Vishwanatha, Jamboor K.

In: PLoS ONE, Vol. 13, No. 10, e0204976, 01.10.2018.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - CRISPR deletion of MIEN1 in breast cancer cells

AU - Van Treuren, Timothy

AU - Vishwanatha, Jamboor K.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-Target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.

AB - Migration and Invasion Enhancer (MIEN1) is an oncogene which is involved in facilitating motility of cancer cells through actin dynamics and gene expression. Increased MIEN1 expression in many types of tumors leads to disease progression and metastatic propensity. It is unclear precisely how MIEN1 is involved in this process and more studies are required to tease out the mechanisms. Here we show that Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) genome editing effectively produced specific genomic deletions in the MIEN1 gene which led to the abrogation of its expression in breast cancer cells. The single guide RNAs (sgRNAs) mediated targeting of MIEN1 was specific and none of the clones screened for off-Target cleavage revealed any insertions or deletions (indels). Additionally, disruption of the MIEN1 gene did not alter the cell morphology, growth, proliferation or survival. Knocking out MIEN1 in these breast cancer cells will allow future studies to determine the exact role MIEN1 plays in breast tumor metastasis, which might lead to production of novel therapeutics to treat this and other cancers.

UR - http://www.scopus.com/inward/record.url?scp=85054466747&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0204976

DO - 10.1371/journal.pone.0204976

M3 - Article

VL - 13

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

IS - 10

M1 - e0204976

ER -